Vanguard Group’s Cabaletta Bio CABA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$5.25M Buy
3,450,727
+606,488
+21% +$922K ﹤0.01% 3199
2025
Q1
$3.94M Sell
2,844,239
-23,483
-0.8% -$32.5K ﹤0.01% 3267
2024
Q4
$6.51M Buy
2,867,722
+314,012
+12% +$713K ﹤0.01% 3156
2024
Q3
$12.1M Buy
2,553,710
+187,653
+8% +$886K ﹤0.01% 2863
2024
Q2
$17.7M Buy
2,366,057
+89,835
+4% +$672K ﹤0.01% 2631
2024
Q1
$38.8M Buy
2,276,222
+144,291
+7% +$2.46M ﹤0.01% 2273
2023
Q4
$48.4M Buy
2,131,931
+163,823
+8% +$3.72M ﹤0.01% 2202
2023
Q3
$30M Buy
1,968,108
+246,596
+14% +$3.75M ﹤0.01% 2372
2023
Q2
$22.2M Buy
1,721,512
+607,569
+55% +$7.84M ﹤0.01% 2544
2023
Q1
$9.21M Buy
1,113,943
+184,754
+20% +$1.53M ﹤0.01% 2981
2022
Q4
$8.59M Sell
929,189
-349,362
-27% -$3.23M ﹤0.01% 3023
2022
Q3
$831K Buy
1,278,551
+226,713
+22% +$147K ﹤0.01% 4060
2022
Q2
$1.12M Hold
1,051,838
﹤0.01% 4048
2022
Q1
$2.14M Buy
1,051,838
+147,346
+16% +$299K ﹤0.01% 3927
2021
Q4
$3.43M Buy
904,492
+173,711
+24% +$658K ﹤0.01% 3809
2021
Q3
$8.89M Buy
730,781
+582
+0.1% +$7.08K ﹤0.01% 3312
2021
Q2
$6.28M Buy
730,199
+36,314
+5% +$312K ﹤0.01% 3471
2021
Q1
$7.7M Buy
693,885
+38,982
+6% +$433K ﹤0.01% 3304
2020
Q4
$8.17M Buy
654,903
+81,573
+14% +$1.02M ﹤0.01% 3098
2020
Q3
$6.22M Buy
573,330
+316,053
+123% +$3.43M ﹤0.01% 3037
2020
Q2
$2.87M Sell
257,277
-47,116
-15% -$525K ﹤0.01% 3325
2020
Q1
$2.22M Buy
304,393
+403
+0.1% +$2.94K ﹤0.01% 3275
2019
Q4
$4.25M Buy
+303,990
New +$4.25M ﹤0.01% 3217